BOSTON, June 16, 2025 ~ As the BIO International Convention kicks off in Boston, Big4Bio and BYTE51 have announced a groundbreaking partnership that will provide the biotech community with unparalleled access to industry news and intelligence.

Big4Bio, known as the premier aggregator of life sciences news and developments, has joined forces with BYTE51, the leading platform for private biotech intelligence. This collaboration offers Big4Bio subscribers an exclusive discounted rate of $1,198 per year for access to BYTE51's powerful tools and insights. This is a significant reduction from the standard annual price of $2,500 and opens up a world of biotech market intelligence that would typically cost up to $20,000 per year through other data providers.

According to Matthew Gibbs, Co-Founder & CEO of BYTE51, this partnership is a game-changer for biotech investing. "BYTE51 was built to level the playing field in biotech investing," he stated. "This partnership with Big4Bio enables broader access to insights that were once reserved for insiders. Whether you're scouting clinical trials, tracking private funding rounds, or spotting early-stage trends, we're giving professionals the visibility they need—at a price that doesn't break the bank."

More on Boston Chron

• Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
• Mayor Wu, Boston Emergency Medical Services Celebrate New EMTs and Recent Promotions
• Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
• InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
• CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH

BYTE51's platform allows users to filter through privately held biotech companies based on various criteria such as scientific indications, mechanisms of action, funding stages, location, capital raised, clinical progress, investors, and partners. This empowers VCs (venture capitalists), business developers, and startup executives to make faster and more strategic decisions.

David J. Whelan, Chief Business Officer of Big4Bio emphasized that this partnership is all about democratizing access to data. "Our community of industry leaders and service providers now have a direct line to a resource that helps them understand the private life sciences landscape and move with greater confidence," he said. "And making it just $1,198 per year—less than the cost of a cup of coffee a day—we expect this will be an immediate win for our readers."

To take advantage of this exclusive offer, interested individuals can visit big4bio.com/byte51. Additionally, Big4Bio will be present at the BIO Convention and RESI Boston conference, and those who wish to meet with them can contact them at [insert contact information]. This partnership between Big4Bio and BYTE51 is set to revolutionize the way the biotech community accesses and utilizes market intelligence, providing a valuable resource for professionals in the industry.

---

Show All News | Disclaimer | Report Violation